GMED · PEAD ↓ 100

Globus Medical reported Q1 2026 EPS of $1.12 on 2026-05-08, beating the $0.9201 consensus by $0.1999 (+21.7%); year-over-year comparison is not available in the current data feed.

Print-day reaction was −8.4% versus the prior close, a sharp sell-the-news reversal despite the meaningful EPS beat. The overnight gap to the T+1 open recovered modestly, adding +1.3%, suggesting a brief stabilisation attempt after the initial plunge. Over the subsequent two trading days the drift continued lower by −1.4%, offering no sustained relief. Cumulative abnormal return of −12.6% versus SPY.US firmly establishes a PEAD short signal; drift confirmed and extended the initial negative reaction, with the holding window running through 2026-08-05.